Epidemiology of non-AD dementias

Clinical Neuroscience Research

Volumn 3, Issue 6, 2004, Pages 349-361

  Bornebroek, Marjolijn ^a,b   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Vlietland Hospital   (Netherlands)

Author keywords

Dementia; Dementia with Lewy bodies; Epidemiology; Frontotemporal dementia; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E4; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TAU PROTEIN;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALLELE; ALZHEIMER DISEASE; ASIA; AUTOPSY; AUTOSOMAL DOMINANT DISORDER; BRAIN ATROPHY; BRAIN INFARCTION; CANADA; CEREBRAL ARTERY DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DEMENTIA WITH LEWY BODIES; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG USE; EDUCATION; EUROPE; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; INCIDENCE; LEUKOENCEPHALOPATHY; MULTIINFARCT DEMENTIA; PRESENILE DEMENTIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENILE DEMENTIA; SEX DIFFERENCE; VASCULAR AMYLOIDOSIS; WHITE MATTER;

EID: 2542486596     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2004.04.002     Document Type: Article

References (159)

1. Fratiglioni L. Launer L.J. Andersen K. et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group Neurology 54 2000 S10-S15
2. Launer L.J. Demonstrating the case that AD is a vascular disease: epidemiologic evidence Ageing Res Rev 1 2002 61-77
3. Pfeifer L.A. White L.R. Ross G.W. Petrovitch H. Launer L.J. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study Neurology 58 2002 1629-1634
4. Hachinski V.C. Iliff L.D. Zilhka E. et al. Cerebral blood flow in dementia Arch Neurol 32 1975 632-637
5. Kalaria R.N. Ballard C.G. Ince P.G. et al. Multiple substrates of late-onset dementia: implications for brain protection Novartis Found Symp 235 2001 49-60
6. Roman G. Diagnosis of vascular dementia and Alzheimer's disease Int J Clin Pract Suppl 2001 9-13
7. Jellinger K.A. The pathology of ischemic-vascular dementia: an update J Neurol Sci 203-204 2002 153-157
8. Hennerici M.G. Oster M. Cohen S. et al. Are gait disturbances and white matter degeneration early indicators of vascular dementia? Dementia 5 1994 197-202
9. Wetterling T. Kanitz R.-D. Borgis K.-J. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN) Stroke 27 1996 30-36
10. World Heath Organisation The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research 1993 World Health Organisation Geneva, Switzerland
11. Roman G.C. Tatemichi T.K. Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250-260
12. Chui H.C. Victoroff J.I. Margolin D. et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers Neurology 42 1992 473-480
13. Wetterling T. Kanitz R.D. Borgis K.J. The ICD-10 criteria for vascular dementia Dementia 5 1994 185-188
14. Association AP. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Ap Association, editor. Washington DC; 1994, p. 143-7.
15. Verhey F.R. Lodder J. Rozendaal N. Jolles J. Comparison of seven sets of criteria used for the diagnosis of vascular dementia Neuroepidemiology 15 1996 166-172
16. Rocca W.A. Hofman A. Brayne C. et al. The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group Ann Neurol 30 1991 817-824
17. Ott A. Breteler M.M. van Harskamp F. et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study Br Med J 310 1995 970-973
18. Ikeda M. Hokoishi K. Maki N. et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study Neurology 57 2001 839-844
19. Yamada T. Hattori H. Miura A. Tanabe M. Yamori Y. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population Psychiatry Clin Neurosci 55 2001 21-25
20. Andersen K. Launer L.J. Dewey M.E. et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group Neurology 53 1999 1992-1997
21. Ruitenberg A. Ott A. van Swieten J.C. Hofman A. Breteler M.M. Incidence of dementia: does gender make a difference? Neurobiol Aging 22 2001 575-580
22. Hebert R. Lindsay J. Verreault R. et al. Vascular dementia: incidence and risk factors in the Canadian study of health and aging Stroke 31 2000 1487-1493
23. Bickel H. Cooper B. Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study Psychol Med 24 1994 179-192
24. Fratiglioni L. Viitanen M. von Strauss E. et al. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm Neurology 48 1997 132-138
25. Andreasen N. Blennow K. Sjodin C. Winblad B. Svardsudd K. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project Neuroepidemiology 18 1999 144-155
26. Liu C.K. Lai C.L. Tai C.T. et al. Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors Neurology 50 1998 1572-1579
27. Zhang M. Katzman R. Yu E. et al. A preliminary analysis of incidence of dementia in Shanghai, China Psychiatry Clin Neurosci 52 Suppl. 1998 S291-S294
28. Li G. Shen Y.C. Chen C.H. et al. A three-year follow-up study of age-related dementia in an urban area of Beijing Acta Psychiatr Scand 83 1991 99-104
29. Knopman D.S. Rocca W.A. Cha R.H. Edland S.D. Kokmen E. Survival study of vascular dementia in Rochester, Minnesota Arch Neurol 60 2003 85-90
30. Aevarsson O. Svanborg A. Skoog I. Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia Arch Neurol 55 1998 1226-1232
31. Aguero-Torres H. Fratiglioni L. Guo Z. Viitanen M. Winblad B. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases J Clin Epidemiol 52 1999 737-743
32. Tatemichi T.K. Desmond D.W. Paik M. et al. Clinical determinants of dementia related to stroke Ann Neurol 33 1993 568-575
33. Tatemichi T.K. Desmond D.W. Mayeux R. et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort Neurology 42 1992 1185-1193
34. Loeb C. Gandolfo C. Croce R. Conti M. Dementia associated with lacunar infarction Stroke 23 1992 1225-1229
35. Vermeer S.E. Den Heijer T. Koudstaal P.J. et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study Stroke 34 2003 392-396
36. Longstreth W.T. Jr Dulberg C. Manolio T.A. et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study Stroke 33 2002 2376-2382
37. Kuller L.H. Lopez O.L. Newman A. et al. Risk factors for dementia in the cardiovascular health cognition study Neuroepidemiology 22 2003 13-22
38. Koga H. Yuzuriha T. Yao H. et al. Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects J Neurol Neurosurg Psychiatry 72 2002 737-741
39. Skoog I. Berg S. Johansson B. Palmertz B. Andreasson L.A. The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds Acta Neurol Scand 93 1996 142-148
40. Launer L.J. Masaki K. Petrovitch H. Foley D. Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study J Am Med Assoc 274 1995 1846-1851
41. Skoog I. Lernfelt B. Landahl S. et al. 15-year longitudinal study of blood pressure and dementia Lancet 347 1996 1141-1145
42. Farmer M.E. Kittner S.J. Abbott R.D. et al. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study J Clin Epidemiol 43 1990 475-480
43. Elias M.F. Wolf P.A. D'Agostino R.B. Cobb J. White L.R. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study Am J Epidemiol 138 1993 353-364
44. Guo Z. Viitanen M. Fratiglioni L. Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project Br Med J 312 1996 805-808
45. Landahl S. Bengtsson C. Sigurdsson J.A. Svanborg A. Svardsudd K. Age-related changes in blood pressure Hypertension 8 1986 1044-1049
46. Ruitenberg A. Skoog I. Ott A. et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study Dement Geriatr Cogn Disord 12 2001 33-39
47. in't Veld B.A. Ruitenberg A. Hofman A. Stricker B.H.C. Breteler M.M.B. Antihypertensive drugs and incidence of dementia: the Rotterdam Study Neurobiol Aging 22 2001 407-412
48. Amenta F. Mignini F. Rabbia F. Tomassoni D. Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data J Neurol Sci 203-204 2002 147-151
49. Frishman W.H. Are antihypertensive agents protective against dementia? A review of clinical and preclinical data Heart Dis 4 2002 380-386
50. Ott A. Slooter A.J. Hofman A. et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study Lancet 351 1998 1840-1843
51. Doll R. Peto R. Boreham J. Sutherland I. Smoking and dementia in male British doctors: prospective study Br Med J 320 2000 1097-1102
52. Stegmayr B. Asplund K. Diabetes as a risk factor for stroke. A population perspective Diabetologia 38 1995 1061-1068
53. Breteler M.M. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective Neurobiol Aging 21 2000 153-160
54. Ott A. Stolk R.P. Hofman A. et al. Association of diabetes mellitus and dementia: the Rotterdam Study Diabetologia 39 1996 1392-1397
55. Ott A. Stolk R.P. van Harskamp F. et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study Neurology 53 1999 1937-1942
56. Peila R. Rodriguez B.L. Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study Diabetes 51 2002 1256-1262
57. Leibson C.L. Rocca W.A. Hanson V.A. et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study Am J Epidemiol 145 1997 301-308
58. Luchsinger J.A. Tang M.X. Stern Y. Shea S. Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort Am J Epidemiol 154 2001 635-641
59. McCall A.L. The impact of diabetes on the CNS Diabetes 41 1992 557-570
60. Mankovsky B.N. Metzger B.E. Molitch M.E. Biller J. Cerebrovascular disorders in patients with diabetes mellitus J Diabetes Complications 10 1996 228-242
61. Munch G. Cunningham A.M. Riederer P. Braak E. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease Brain Res 796 1998 307-310
62. Giubilei F. D'Antona R. Antonini R. et al. Serum lipoprotein pattern variations in dementia and ischemic stroke Acta Neurol Scand 81 1990 84-86
63. Moroney J.T. Tang M.-X. Berglund L. et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke J Am Med Assoc 282 1999 254-260
64. Ross G.W. Petrovitch H. White L.R. et al. Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study Neurology 53 1999 337-343
65. Engelhart M.J. Geerlings M.I. Ruitenberg A. et al. Diet and risk of dementia: does fat matter? The Rotterdam Study Neurology 59 2002 1915-1921
66. Yaffe K. Barrett-Connor E. Lin F. Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women Arch Neurol 59 2002 378-384
67. Etminan M. Gill S. Samii A. The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies Pharmacotherapy 23 2003 726-730
68. French L.R. Schuman L.M. Mortimer J.A. et al. A case-control study of dementia of the Alzheimer type Am J Epidemiol 121 1985 414-421
69. Gronbaek M. Deis A. Sorensen T.I. et al. Mortality associated with moderate intakes of wine, beer, or spirits Br Med J 310 1995 1165-1169
70. Berger K. Ajani U.A. Kase C.S. et al. Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians N Engl J Med 341 1999 1557-1564
71. Rimm E.B. Klatsky A. Grobbee D. Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits Br Med J 312 1996 731-736
72. Fenn C.G. Littleton J.M. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition Thromb Haemost 48 1982 49-53
73. Miller N.E. Bolton C.H. Hayes T.M. et al. Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies J Epidemiol Community Health 42 1988 220-225
74. Henn C. Loffelholz K. Klein J. Stimulatory and inhibitory effects of ethanol on hippocampal acetylcholine release Naunyn Schmiedebergs Arch Pharmacol 357 1998 640-647
75. Mukamal K.J. Longstreth W.T. Jr Mittleman M.A. Crum R.M. Siscovick D.S. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study Stroke 32 2001 1939-1946
76. Orgogozo J.M. Dartigues J.F. Lafont S. et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area Rev Neurol (Paris) 153 1997 185-192
77. Broustet J.P. Wine and health Heart 81 1999 459-460
78. Truelsen T. Thudium D. Gronbaek M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study Neurology 59 2002 1313-1319
79. Launer L.J. Feskens E.J. Kalmijn S. Kromhout D. Smoking, drinking, and thinking. The Zutphen Elderly Study Am J Epidemiol 143 1996 219-227
80. Galanis D.J. Joseph C. Masaki K.H. et al. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study Am J Public Health 90 2000 1254-1259
81. Ruitenberg A. van Swieten J.C. Witteman J.C. et al. Alcohol consumption and risk of dementia: the Rotterdam Study Lancet 359 2002 281-286
82. Mukamal K.J. Kuller L.H. Fitzpatrick A.L. et al. Prospective study of alcohol consumption and risk of dementia in older adults J Am Med Assoc 289 2003 1405-1413
83. Ott A. van Rossum C.T. van Harskamp F. et al. Education and the incidence of dementia in a large population-based study: the Rotterdam Study Neurology 52 1999 663-666
84. Katzman R. Education and the prevalence of dementia and Alzheimer's disease Neurology 43 1993 13-20
85. Lindsay J. Hebert R. Rockwood K. The Canadian Study of Health and Aging: risk factors for vascular dementia Stroke 28 1997 526-530
86. Gorelick P.B. Brody J. Cohen D. et al. Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients Arch Neurol 50 1993 714-720
87. Mortel K.F. Meyer J.S. Herod B. Thornby J. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types Dementia 6 1995 55-62
88. McGeer P.L. McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases Brain Res Brain Res Rev 21 1995 195-218
89. van Bockxmeer F.M. Mamotte C.D. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease Lancet 340 1992 879-880
90. de Knijff P. van Duijn C.M. Role of APOE in dementia: a critical reappraisal Haemostasis 28 1998 195-201
91. Hofman A. Ott A. Breteler M.M. et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Lancet 349 1997 151-154
92. Slooter A.J. Tang M.X. van Duijn C.M. et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation J Am Med Assoc 277 1997 818-821
93. Treves T.A. Bornstein N.M. Chapman J. et al. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia Alzheimer Dis Assoc Disord 10 1996 189-191
94. Noguchi S. Murakami K. Yamada N. Apolipoprotein E genotype and Alzheimer's disease Lancet 342 1993 737
95. Frank A. Diez-Tejedor E. Bullido M.J. Valdivieso F. Barreiro P. APOE genotype in cerebrovascular disease and vascular dementia J Neurol Sci 203-204 2002 173-176
96. Traykov L. Rigaud A.-S. Baudic S. et al. Apolipoprotein E [epsiv]4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease J Neurol Sci 203-204 2002 177-181
97. Huang H.M. Kuo Y.M. Ou H.C. Lin C.C. Chuo L.J. Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population J Neural Transm 109 2002 1415-1421
98. Arbustini E. Grasso M. Fasani R. et al. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction Br Heart J 74 1995 584-591
99. Erdos E.G. Skidgel R.A. The angiotensin I-converting enzyme Lab Invest 56 1987 345-348
100. Markus H.S. Barley J. Lunt R. et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma Stroke 26 1995 1329-1333
101. Amouyel P. Richard F. Cottel D. et al. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment Neurosci Lett 217 1996 203-205
102. Palumbo B. Cadini D. Nocentini G. et al. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders Neurosci Lett 267 1999 97-100
103. Boers G.H. Smals A.G. Trijbels F.J. et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease N Engl J Med 313 1985 709-715
104. Kluijtmans L.A. van den Heuvel L.P. Boers G.H. et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease Am J Hum Genet 58 1996 35-41
105. Chapman J. Wang N. Treves T.A. Korczyn A.D. Bornstein N.M. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia Stroke 29 1998 1401-1404
106. Pollak R.D. Pollak A. Idelson M. et al. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia J Am Geriatr Soc 48 2000 664-668
107. Blatter M.C. James R.W. Messmer S. Barja F. Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase Eur J Biochem 211 1993 871-879
108. Watson A.D. Berliner J.A. Hama S.Y. et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882-2891
109. Mackness M.I. Harty D. Bhatnagar D. et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus Atherosclerosis 86 1991 193-199
110. Laplaud P.M. Dantoine T. Chapman M.J. Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses Clin Chem Lab Med 36 1998 431-441
111. Dantoine T.F. Drouet M. Debord J. et al. Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease Ann N Y Acad Sci 977 2002 239-244
112. Adkins S. Gan K.N. Mody M. La Du B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes Am J Hum Genet 52 1993 598-608
113. Zuliani G. Ble A. Zanca R. et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia Acta Neurol Scand 103 2001 304-308
114. Brown M.S. Goldstein J.L. How LDL receptors influence cholesterol and atherosclerosis Sci Am 251 1984 58-66
115. Kuller L.H. Prevention of cardiovascular disease and the future of cardiovascular disease epidemiology Int J Epidemiol 30 Suppl. 1 2001 S66-S72
116. Scacchi R. De Bernardini L. Mantuano E. et al. DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease Dement Geriatr Cogn Disord 9 1998 186-190
117. Schonfeld G. Genetic variation of apolipoprotein B can produce both low and high levels of apoB-containing lipoproteins in plasma Can J Cardiol 11 Suppl. G 1995 86G-92G
118. Ludwig E. Hopkins P. Allen A. et al. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins J Lipid Res 38 1997 1361-1373
119. Wragg M. Hutton M. Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group Lancet 347 1996 509-512
120. Matsushita S. Arai H. Muramatsu T. et al. Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia Exp Neurol 146 1997 567-569
121. Ji Y. Urakami K. Wada-Isoe K. Adachi Y. Nakashima K. Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia Dement Geriatr Cogn Disord 11 2000 119-122
122. Kesslak J.P. Can estrogen play a significant role in the prevention of Alzheimer's disease? J Neural Transm Suppl 2002 227-239
123. Zec R.F. Trivedi M.A. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review Neuropsychol Rev 12 2002 65-109
124. Desmond D.W. Moroney J.T. Lynch T. et al. The natural history of CADASIL: a pooled analysis of previously published cases Stroke 30 1999 1230-1233
125. O'Sullivan M. Jarosz J.M. Martin R.J. et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL Neurology 56 2001 628-634
126. van Den Boom R. Lesnik Oberstein S.A. van Duinen S.G. et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Radiology 224 2002 791-796
127. Kalimo H. Ruchoux M.M. Viitanen M. Kalaria R.N. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia Brain Pathol 12 2002 371-384
128. Skoog I. Davidsson P. Aevarsson Ó. et al. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds Dement Geriatr Cogn Disord 15 2003 169-176
129. Revesz T. Holton J.L. Lashley T. et al. Sporadic and familial cerebral amyloid angiopathies Brain Pathol 12 2002 343-357
130. Bornebroek M. Haan J. Roos R.A. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): a review of the variety in phenotypic expression Amyloid 6 1999 215-224
131. McKeith I.G. Dementia with Lewy bodies Br J Psychiatry 180 2002 144-147
132. McKeith I.G. Galasko D. Kosaka K. et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113-1124
133. Walker Z. Allen R.L. Shergill S. Mullan E. Katona C.L. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies Int J Geriatr Psychiatry 15 2000 267-273
134. Ishikawa A. Takahashi H. Tanaka H. Hayashi T. Tsuji S. Clinical features of familial diffuse Lewy body disease Eur Neurol 38 Suppl. 1 1997 34-38
135. Wakabayashi K. Hayashi S. Ishikawa A. et al. Autosomal dominant diffuse Lewy body disease Acta Neuropathol (Berlin) 96 1998 207-210
136. Ohara K. Takauchi S. Kokai M. et al. Familial dementia with Lewy bodies (DLB) Clin Neuropathol 18 1999 232-239
137. Stevens T. Livingston G. Kitchen G. et al. Islington study of dementia subtypes in the community Br J Psychiatry 180 2002 270-276
138. Singleton A.B. Wharton A. O'Brien K.K. et al. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies Dement Geriatr Cogn Disord 14 2002 167-175
139. Tsuang D.W. Dalan A.M. Eugenio C.J. et al. Familial dementia with Lewy Bodies: a clinical and neuropathological study of 2 families Arch Neurol 59 2002 1622-1630
140. Harrington C.R. Louwagie J. Rossau R. et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease Am J Pathol 145 1994 1472-1484
141. Neary D. Snowden J. Gustafson L. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546-1554
142. Greicius M.D. Geschwind M.D. Miller B.L. Presenile dementia syndromes: an update on taxonomy and diagnosis J Neurol Neurosurg Psychiatry 72 2002 691-700
143. Snowden J.S. Neary D. Mann D.M. Frontotemporal dementia Br J Psychiatry 180 2002 140-143
144. Ratnavalli E. Brayne C. Dawson K. Hodges J.R. The prevalence of frontotemporal dementia Neurology 58 2002 1615-1621
145. anonymous Consensus statement. Clinical and neuropathological criteria for fronto-temporal dementia. The Lund and Manchester groups J Neurol Neurosurg Psychiatry 4 1994 416-418
146. Stevens M. van Duijn C.M. Kamphorst W. et al. Familial aggregation in frontotemporal dementia Neurology 50 1998 1541-1545
147. Gislason T.B. Sjogren M. Larsson L. Skoog I. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds J Neurol Neurosurg Psychiatry 74 2003 867-871
148. Rosso S. Frontotemporal dementia in the Netherlands In: Neurology 2003 Erasmus University Rotterdam Rotterdam
149. van Slegtenhorst M. Lewis J. Hutton M. The molecular genetics of the tauopathies Exp Gerontol 35 2000 461-471
150. Ingelson M. Fabre S.F. Lilius L. et al. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4 NeuroReport 12 2001 905-909
151. Morris H.R. Janssen J.C. Bandmann O. et al. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases J Neurol Neurosurg Psychiatry 66 1999 665-667
152. Verpillat P. Camuzat A. Hannequin D. et al. Association between the extended tau haplotype and frontotemporal dementia Arch Neurol 59 2002 935-939
153. Stevens M. van Duijn C.M. de Knijff P. et al. Apolipoprotein E gene and sporadic frontal lobe dementia Neurology 48 1997 1526-1529
154. Geschwind D. Karrim J. Nelson S.F. Miller B. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia Ann Neurol 44 1998 134-138
155. Houlden H. Rizzu P. Stevens M. et al. Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations Neurosci Lett 260 1999 193-195
156. Pickering-Brown S.M. Owen F. Isaacs A. et al. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology Exp Neurol 163 2000 452-456
157. Geroldi C. Pihlajamaki M. Laakso M.P. et al. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD Neurology 53 1999 1825-1832
158. Rosso S.M. Roks G. Cruts M. et al. Apolipoprotein E4 in the temporal variant of frontotemporal dementia J Neurol Neurosurg Psychiatry 72 2002 820
159. Rosso S.M. van Swieten J.C. New developments in frontotemporal dementia and parkinsonism linked to chromosome 17 Curr Opin Neurol 15 2002 423-428